Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000575107 | SCV000664845 | likely benign | Hereditary cancer-predisposing syndrome | 2025-03-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000575107 | SCV000684971 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001498789 | SCV001703542 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-10-30 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV004596218 | SCV005090939 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005247082 | SCV005899928 | likely benign | Lynch syndrome 1 | 2024-12-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |